HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd

HMDCF · OTC · Health Technology, Pharmaceuticals Major · Founded 2000

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments.

Current Price
—
Market Cap
—
Return Since Last Split
-65%
Last Split
May 30, 2019
Total Splits
1
Cumulative Multiple
10×

What If You Bought HMDCF Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
1,000 shares · 10×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
May 30, 2019$6.1610-for-110×10×

HUTCHMED (China) Ltd Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

HUTCHMED (China) Ltd's latest record in the split calendar is a 10-for-1 forward split effective 2019-05-30.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.